[1]屈 慧,李 娅.肾功能及电解质水平变异性与慢性心力衰竭患者预后相关性研究[J].陕西医学杂志,2023,52(3):287-291.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.009]
　QU Hui,LI Ya.Correlation between variability of renal function and electrolyte levels and prognosis of patients with chronic heart failure[J].,2023,52(3):287-291.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.009]
点击复制

肾功能及电解质水平变异性与慢性心力衰竭患者预后相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年3期
页码:
287-291
栏目:
临床研究
出版日期:
2023-03-05

文章信息/Info

Title:
Correlation between variability of renal function and electrolyte levels and prognosis of patients with chronic heart failure
作者:
屈 慧1; 李 娅2
(1.空军军医大学西京医院检验科,陕西 西安710032; 2.西安市人民医院 西安市第四医院检验科,陕西 西安 710004)
Author(s):
QU Hui; LI Ya
(Department of Laboratory,Xijing Hospital,Air Force Medical University,Xi'an 710032,China)
关键词:
慢性心力衰竭;  肾功能;  电解质;  预后分析;  相关性
Keywords:
Chronic heart failure;  Renal function;  Electrolyte;  Prognostic analysis;  Correlation
分类号:
R 541.6
DOI:
DOI:10.3969/j.issn.1000-7377.2023.03.009
文献标志码:
A
摘要:
目的:探讨肾功能及电解质水平变异性与慢性心力衰竭(CHF)患者预后的相关性。方法:选择CHF患者572例为研究对象,每月到门诊进行常规复诊,每2个月进行实验室检查[血清尿素氮(BUN)、肌酐(Cr)、血清电解质(Na+、K+、Cl-、Ca2+及Mg2+)]和心脏彩超检查[左心室射血分数(LVEF)],持续6个月。计算持续复诊期间上述指标的平均值(mean)及平均连续变异系数(ASV)作为变异性相关指标。而后对患者进行为期2年的随访,根据预后情况将患者分为预后良好组和预后不良组。比较两组一般资料、实验室检查及心脏彩超检查变异性指标。采用比例风险回归模型(Cox)分析影响患者预后的因素。结果:截至2021年6月31日随访结束,572例患者中509例患者完成各项检查及随访,完成率88.98%; 预后不良患者133例,其中心血管意外43例,心脏原因急诊再入院88例,心脏原因死亡2例。最终,预后良好组376例,预后不良组133例。预后不良组SBP、DBP、NYHA分级Ⅳ级占比、卒中类疾病占比高于预后良好组(均P<0.05)。预后不良组FBG-mean、FBG-ASV、BUN-ASV、Cr-mean、Cr-ASV、Na+-ASV、K+-ASV、Ca2+-ASV、Mg2+-ASV及LVEF-ASV高于预后良好组,LVEF-mean低于预后良好组(均P<0.05)。Cox回归分析结果显示,SBP-ASV、DBP-ASV、NYHA分级Ⅳ级、FBG-ASV、BUN-ASV、Cr-ASV、K+-ASV、Ca2+-ASV、Mg2+-ASV及LVEF-ASV是影响CHF患者预后的独立危险因素,而LVEF-mean是保护因素(均P<0.05)。结论:肾功能及电解质水平的变异性与CHF患者预后显著相关,为CHF患者长期管理提供了新的参考方向。
Abstract:
Objective:To investigate the correlation between the variability of renal function and electrolyte levels and the prognosis of patients with chronic heart failure(CHF).Methods:A total of 572 patients with CHF were selected as the research object.They went to the outpatient department for routine follow-up every month.Laboratory tests [serum urea nitrogen(BUN),creatinine(Cr),serum electrolytes(Na+,K+,Cl-,Ca2+ and Mg2+)] and color Doppler echocardiography [left ventricular ejection fraction(LVEF)] were performed every 2 months for 6 months.The mean and the average continuous coefficient of variation(ASV)of the above indicators were calculated as the variability related indicators during the continuous follow-up visit.Then the patients were followed up for 2 years,and were divided into good prognosis group and poor prognosis group according to the prognosis.The general data,the variability of laboratory tests and cardiac color Doppler echocardiography were compared between the two groups.of Factors affecting the prognosis of patients was analyed by Cox.Results:By the end of follow-up on June 31,2021,509 of 572 patients had completed various examinations and follow-up,with a completion rate of 88.98%; 133 patients had poor prognosis,including 43 cardiovascular accidents,88 emergency readmissions due to cardiac causes,and 2 deaths due to cardiac causes.Finally,376 patients had good prognosis and 133 patients had poor prognosis.The proportions of SBP,DBP,NYHA grade Ⅳ and stroke in poor prognosis group were higher than those in good prognosis group(all P<0.05).The FBG-mean、FBG-ASV、BUN-ASV、Cr-mean、Cr-ASV、Na+-ASV、K+-ASV、Ca2+-ASV、Mg2+-ASV and LVEF-ASV in poor prognosis group were higher than those in good prognosis group,LVEF mean was lower than that in good prognosis group(all P<0.05).Cox regression analysis showed that SBP-ASV、DBP-ASV、NYHA grade Ⅳ、FBG-ASV、BUN-ASV、Cr-ASV、K+-ASV、Ca2+-ASV、Mg2+-ASV and LVEF-ASV were independent risk factors for prognosis of patients with CHF,but LVEF mean was a protective factor(all P<0.05).Conclusion:The variability of renal function and electrolyte levels are significantly related to the prognosis of CHF patients,which provides a new direction for long-term management of CHF patients.

参考文献/References:

[1] 李 刚,陈紫凡.左西孟旦治疗老年慢性心力衰竭患者临床疗效及对患者心功能、肾素-血管紧张素-醛固酮系统的影响[J].陕西医学杂志,2020,49(10):1321-1324.
[2] Rossignol P,Hernandez AF,Solomon SD,et al.Heart failure drug treatment[J].Lancet,2019,393(10175):1034-1044.
[3] Haynes R,Zhu D,Judge PK,et al.Chronic kidney disease,heart failure and neprilysin inhibition[J].Nephrol Dial Transplant,2020,35(4):558-564.
[4] 王 毅,杨 征.托伐普坦和沙库巴曲缬沙坦钠片对慢性心力衰竭患者心功能及血清钠水平的影响研究[J].陕西医学杂志,2019,48(4):470-472.
[5] Romero-González G,Ravassa S,González O,et al.Burden and challenges of heart failure in patients with chronic kidney disease.A call to action[J].Nefrologia(Engl Ed),2020,40(3):223-236.
[6] Zhu Y,Lu JM,Yu ZB,et al.Intra-individual variability of total cholesterol is associated with cardiovascular disease mortality:A cohort study[J].Nutr Metab Cardiovasc Dis,2019,29(11):1205-1213.
[7] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122.
[8] 上海慢性肾脏病早发现及规范化诊治与示范项目专家组.慢性肾脏病筛查、诊断及防治指南[J].中国实用内科杂志,2017,37(1):28-34.
[9] 寇林利,赵明君,魏明明,等.苓桂术甘汤对慢性心力衰竭大鼠心肌功能及心室重构的影响[J].陕西中医,2022,43(9):1170-1174.
[10] 中华医学会,中华医学会临床药学分会,中华医学会杂志社,等.慢性心力衰竭基层合理用药指南[J].中华全科医师杂志,2021,20(1):42-49.
[11] Birkeland KI,Bodegard J,Eriksson JW,et al.Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes:A large multinational cohort study[J].Diabetes Obes Metab,2020,22(9):1607-1618.
[12] Tsuchida K,Hirose H,Ozawa S,et al.Monensin-induced increase in intracellular Na+ induces changes in Na+ and Ca2+ currents and regulates Na+-K+ and Na+-Ca2+ transport in cardiomyocytes[J].Pharmacology,2021,106(1-2):91-105.
[13] König P,Mayer O,Bruthans J,et al.The prognostic importance of subclinical heart failure in stable coronary heart disease patients[J].Acta Cardiol,2020,75(4):329-336.
[14] Kim GH,Uriel N,Burkhoff D.Reverse remodelling and myocardial recovery in heart failure[J].Nat Rev Cardiol,2018,15(2):83-96.
[15] Jones NR,Roalfe AK,Adoki I,et al.Survival of patients with chronic heart failure in the community:A systematic review and meta-analysis[J].Eur J Heart Fail,2019,21(11):1306-1325.
[16] Vecchié A,Dallegri F,Carbone F,et al.Obesity phenotypes and their paradoxical association with cardiovascular diseases[J].Eur J Intern Med,2018,48:6-17.
[17] Sciomer S,Moscucci F,Salvioni E,et al.Role of gender,age and BMI in prognosis of heart failure[J].Eur J Prev Cardiol,2020,27(2_suppl):46-51.
[18] Ye N,Yang L,Wang G,et al.Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes:Findings from the improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome(CCC-ACS)project[J].BMC Cardiovasc Disord,2020,20(1):380.
[19] Llauger L,Jacob J,Miró .Renal function and acute heart failure outcome[J].Med Clin(Barc),2018,151(7):281-290.
[20] Mizuguchi Y,Konishi T,Nagai T,et al.Prognostic value of admission serum magnesium in acute myocardial infarction complicated by malignant ventricular arrhythmias[J].Am J Emerg Med,2021,44:100-105.
[21] Ma C,Luo H,Fan L,et al.Heart failure with preserved ejection fraction:An update on pathophysiology,diagnosis,treatment,and prognosis[J].Braz J Med Biol Res,2020,53(7):e9646.

相似文献/References:

[1]王 毅,杨 征.托伐普坦和沙库巴曲缬沙坦钠片对慢性心力衰竭患者心功能及血清钠水平的影响研究[J].陕西医学杂志,2019,(4):470.
[2]张静雯,汪 宁,邱红霞,等.非布司他治疗早期糖尿病肾病合并高尿酸血症疗效及对患者肾功能影响研究*[J].陕西医学杂志,2020,49(2):209.
　ZHANG Jingwen,WANG Ning,QIU Hongxia,et al.Efficacy of febuxostat on early diabetic nephropathy with hyperuricemia and its effect on renal function[J].,2020,49(3):209.
[3]李 刚,陈紫凡△.左西孟旦治疗老年慢性心力衰竭患者临床疗效及对患者心功能、肾素-血管紧张素-醛固酮系统的影响[J].陕西医学杂志,2020,49(10):1321.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.032]
　LI Gang,CHEN Zifan..Curative effect of levosimendan in treatment of elderly patients with chronic heart failure and its influence on cardiac function and renin-angiotensin-aldosterone system[J].,2020,49(3):1321.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.032]
[4]杨 帆,高 盼.血小板参数、D-二聚体在妊娠高血压综合征早期肾损伤患者中的表达及临床意义[J].陕西医学杂志,2021,50(4):413.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.007]
　YANG Fan,GAO Pan.Expression and clinical significance of platelet parameters and D-dimer in patients with early-stage renal injury in pregnancy-induced hypertension syndrome[J].,2021,50(3):413.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.007]
[5]赵素玲,任伟宏.老年女性高血压患者血清性激素水平与肾功能相关性研究[J].陕西医学杂志,2021,50(4):432.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.012]
[6]申文文,延欢欢.不同类型慢性心力衰竭患者血清肌钙蛋白T和N末端B型钠尿肽原水平变化及临床意义[J].陕西医学杂志,2021,50(9):1109.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.017]
　SHEN Wenwen,YAN Huanhuan.Changes and clinical significance of serum TnT and NT-proBNP levelsin patients with different types of CHF[J].,2021,50(3):1109.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.017]
[7]刘娜娜,解凤妮.糖皮质激素对急性重症胰腺炎大鼠肾功能及肠功能的改善作用实验研究[J].陕西医学杂志,2021,50(10):1195.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.005]
　LIU Na'na,XIE Fengni.Effect of glucocorticoid on improving renal function and intestinal function in rats with severe acute pancreatitis[J].,2021,50(3):1195.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.005]
[8]马 飞,刘 琳.肾衰宁片对单侧输尿管梗阻大鼠肾间质纤维化的改善作用及机制研究[J].陕西医学杂志,2022,51(6):654.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.003]
　MA Fei,LIU Lin.Improvement of Shenshuaining tablet on renal interstitial fibrosis in rats with unilateral ureteral obstruction and its mechanism[J].,2022,51(3):654.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.003]
[9]陈金权,王 蕊.右美托咪定对慢性心力衰竭大鼠的作用及机制研究[J].陕西医学杂志,2022,51(6):664.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.005]
　CHEN Jinquan,WANG Rui.Effect and mechanism of dexmedetomidine on chronic heart failure in rats[J].,2022,51(3):664.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.005]
[10]刘 康,田 道.胸段硬膜外阻滞治疗急性重症胰腺炎疗效及对患者肾功能的影响[J].陕西医学杂志,2022,51(7):839.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.017]

备注/Memo

备注/Memo:
基金项目:陕西省科技厅一般项目-社会发展领域(2022SF-289)
更新日期/Last Update: 2023-03-06